HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The morphogenic function of E-cadherin-mediated adherens junctions in epithelial ovarian carcinoma formation and progression.

Abstract
E-cadherin expression is unusually regulated in epithelial ovarian carcinoma. It is not expressed in poorly cohesive ovarian surface epithelial (OSE) target cells, but is expressed in cohesive pre-malignant lesions and in highly cohesive, well-differentiated tumors where it is membrane associated, presumably in adherens junctions. E-cadherin expression is subsequently suppressed, or its function is disrupted, in late-stage invasive tumors. Here, we observed that increased E-cadherin expression in ovarian carcinoma cells was associated with increased E-cadherin promoter activity, increased adherens junction formation, decreased beta-catenin signaling-dependent LEF-1 activity, and the generation of cohesive spheroids in basement membrane gel culture. Forced expression of wild-type E-cadherin in immortalized OSE cells initiated adherens junction formation, decreased LEF-1 activity, decreased the mesenchymal migration that is a characteristic of OSE cells that have been maintained in monolayer culture, and induced the formation of cohesive spheroids in basement membrane gels. Conversely, forced expression of a dominant-negative E-cadherin mutant in ovarian carcinoma cells disrupted adherens junctions, increased mesenchymal cell migration, and prevented spheroidal morphogenesis without altering LEF-1 signaling. Therefore, in addition to suppressing late-stage tumor progression, E-cadherin-mediated adherens junctions may also contribute to the initial emergence of a cohesive morphogenic phenotype that is a hallmark of differentiated epithelial ovarian carcinoma.
AuthorsColleen Wu, Jane Cipollone, Sarah Maines-Bandiera, Clara Tan, Aly Karsan, Nelly Auersperg, Calvin D Roskelley
JournalDifferentiation; research in biological diversity (Differentiation) Vol. 76 Issue 2 Pg. 193-205 (Feb 2008) ISSN: 1432-0436 [Electronic] England
PMID17608733 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cadherins
  • Lymphoid Enhancer-Binding Factor 1
Topics
  • Adherens Junctions (metabolism)
  • Cadherins (metabolism)
  • Carcinoma (metabolism, pathology)
  • Cell Line, Tumor
  • Cell Proliferation
  • Epithelial Cells (cytology)
  • Female
  • Humans
  • Lymphoid Enhancer-Binding Factor 1 (metabolism)
  • Ovarian Neoplasms (metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: